Conservative treatment approach with botulinum toxin for cases of asymptomatic hypertrophy of the masseter muscle
DOI:
https://doi.org/10.33448/rsd-v9i10.8935Keywords:
Botulinum Toxins, Type A; Hypertrophy; Masseter muscle.Abstract
Commonly related to parafunctional habits, Masseteric Hypertrophy represents an asymptomatic increase of the lower third of the face. Without gender preference, it has been shown to be prevalent in the second and third decades of life. As an alternative to surgical treatment, the use of Botulinum Toxin A has been increasingly effective in desired clinical results, such as reduced muscle thickness. This study aims to report the case of application of Botulinum Toxin A in an asymptomatic patient who presented bilateral hypertrophy of the masseter muscle, with 120 days follow-up of application where we observed improvement in facial aesthetics due to the reduction in volume of the muscles.
References
Al-Muharraqi, M. A., Fedorowicz, Z., Al Bareeq, J., Al Bareeq, R., & Nasser, M. (2009). Botulinum toxin for masseter hypertrophy. The Cochrane database of systematic reviews, (1), CD007510. https://doi.org/10.1002/14651858.CD007510.pub2
Ahn, K. Y., & Kim, S. T. (2007). The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Plastic and reconstructive surgery, 120(6), 1662–1666. https://doi.org/10.1097/01.prs.0000282309.94147.22
Baş, B., Ozan, B., Muğlali, M., & Celebi, N. (2010). Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases. Medicina oral, patologia oral y cirugia bucal, 15(4), 649–652.
Fedorowicz, Z., van Zuuren, E. J., & Schoones, J. (2013). Botulinum toxin for masseter hypertrophy. The Cochrane database of systematic reviews, (9), CD007510. https://doi.org/10.1002/14651858.CD007510.pub3
Gart, M. S., & Gutowski, K. A. (2016). Overview of Botulinum Toxins for Aesthetic Uses. Clinics in plastic surgery, 43(3), 459–471. https://doi.org/10.1016/j.cps.2016.03.003
Gedrange, T., Gredes, T., Spassov, A., Mai, R., Kuhn, D. U., Dominiak, M., & Kunert-Keil, C. (2013). Histological changes and changes in the myosin mRNA content of the porcine masticatory muscles after masseter treatment with botulinum toxin A. Clinical oral investigations, 17(3), 887–896. https://doi.org/10.1007/s00784-012-0750-0
Ham J. W. (2009). Masseter muscle reduction procedure with radiofrequency coagulation. Journal of Oral & Maxillofacial Surgery, 67(2), 457–463. https://doi.org/10.1016/j.joms.2006.04.012
Kim, H. J., Yum, K. W., Lee, S. S., Heo, M. S., & Seo, K. (2003). Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatologic surgery, 29(5), 484–489. https://doi.org/10.1046/j.1524-4725.2003.29117.x
Kim, J. H., Shin, J. H., Kim, S. T., & Kim, C. Y. (2007). Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle. Plastic and reconstructive surgery, 119(2), 711–717. https://doi.org/10.1097/01.prs.0000239453.67423.99
Know, JS., Kim, ST., Jeon, YM., & Choi, JH. (2009). Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate. International Journal of Oral & Maxillofacial Surgery, 38(4):316-320. . https://doi.org/10.1016/j.ijom.2009.01.008
Lee, EI., Kim, NH., Park, RH., Park, JB., & Ahn, TJ. (2016). Botulinum Toxin Type A for Treatment of Masseter Hypertrophy: Volumetric Analysis of Masseter Muscle Reduction over Time. Archives of Aesthetic Plastic Surgery, 22(2):79-86. https://doi.org/10.14730/aaps.2016.22.2.79
Mandel, L., & Tharakan, M. (1999). Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report. Journal of Oral & Maxillofacial Surgery, 57(8), 1017–1019. https://doi.org/10.1016/s0278-2391(99)90029-0
Pereira A.S. et al. (2018). Metodologia da pesquisa científica. [eBook]. Santa Maria. 1ª Ed. UAB / NTE / UFSM
Pereira Júnior, AJA., Carvalho, PAG., & Pereira, FL. (2009). Treatment of masticatory muscle hypertrophy with botulinum toxin type A. HU Revista, 35(4), 315-319.
Shetty, N., Malaviya, R. K., & Gupta, M. K. (2012). Management of unilateral masseter hypertrophy and hypertrophic scar-a case report. Case reports in dentistry, 2012, 521427. https://doi.org/10.1155/2012/521427
To, E. W., Ahuja, A. T., Ho, W. S., King, W. W., Wong, W. K., Pang, P. C., & Hui, A. C. (2001). A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. British journal of plastic surgery, 54(3), 197–200. https://doi.org/10.1054/bjps.2000.3526
Vasileva R. (2018). Mаsseter Muscle Hypertrophy in Dentistry. Scripta Scientifica Medicinae Dentalis, 4(1):15-19.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Izabella Sol; Cristiano Elias Figueiredo; Cristóvão Marcondes de Castro Rodrigues; Henrique Caetano Parreira de Menezes; Paulo Vinícius Soares; Marcelo Caetano Parreira da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
